A randomized trial and the treatment of pemphigus vulgaris

The Journal of Investigative Dermatology
David J Margolis

Abstract

Pemphigus vulgaris is a rare, life-threatening autoimmune disease. Mycophenolate mofetil is a potent immunosuppressant medication approved by the Food and Drug Administration to be used after solid organ transplantation and to treat pemphigus vulgaris. Mycophenolate mofetil has not become the "wonder drug" that had been anticipated based on initial clinical reports. Studies like that reported by Beissert et al. in this issue are essential to improve dermatologic care.

References

Aug 22, 2007·Archives of Dermatology·Giuseppe CianchiniPietro Puddu
Jul 2, 2009·The British Journal of Dermatology·G MarazzaUNKNOWN Autoimmune bullous disease Swiss study group
Sep 5, 2009·Clinical Medicine : Journal of the Royal College of Physicians of London·Richard W Groves
Apr 3, 2010·PLoS Medicine·H Bart van der WorpMalcolm R Macleod
Apr 23, 2010·The Journal of Investigative Dermatology·Stefan BeissertGrant J Anhalt

❮ Previous
Next ❯

Citations

Feb 14, 2014·The Journal of Dermatological Treatment·Spyridoula DoukakiMaria Rita Bongiorno
Jan 5, 2011·Expert Opinion on Drug Metabolism & Toxicology·Spyridoula DoukakiMaria Rita Bongiorno
Oct 3, 2019·Expert Review of Clinical Immunology·Rebecca L YanovskyA Razzaque Ahmed

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Gang LiYu-Quan Wei
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
M DusaudA Houlgatte
European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
S Montel, C Bungener
Current Treatment Options in Neurology
Patrick M. Grogan, Jonathan S. Katz
© 2021 Meta ULC. All rights reserved